Skip to main content Help with accessibility Skip to main navigation

Budesonide orodispersible tablets (Jorveza®▼) for inducing remission of eosinophilic oesophagitis in adults

CCG Approval Status:

Date Added: 29 - Jul - 2021

The Pan Mersey Area Prescribing Committee recommends the prescribing of BUDESONIDE orodispersible tablets (Jorveza®▼), by specialists only, as a treatment option for inducing remission eosinophilic oesophagitis in adults (older than 18 years of age) in accordance with NICE TA708.